title: Prognostic value of dipyridamole stress echocardiography in hypertensive patients with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
abstract: BACKGROUND
  Hypertension is a major cardiovascular risk factor in the development of coronary artery disease (CAD); therefore, evaluating the presence of CAD is a primary clinical goal. However, the noninvasive tests that are commonly used have poor diagnostic specificity, particularly in patients with left ventricular hypertrophy.
  
  
  OBJECTIVE
  To assess the prognostic value of dipyridamole stress echocardiography (DET) for ischemic events in a subset of patients with hypertension with left ventricular hypertrophy, chest pain and resting electrocardiographic repolarization abnormalities.
  
  
  METHODS
  Eighty-two patients (48 men and 34 women; average age 65+/-7.2 years with left ventricular hypertrophy documented echocardiographically (left ventricular mass index greater than 50 g/h(2.7)), and resting ST segment shift of 0.1 mV or more from baseline at 80 ms after J point in at least two contiguous leads, were submitted to DET according to high-dosage protocol and coadministered with atropine.
  
  
  RESULTS
  The follow-up period was 25.11+/-8.3 months. The stress test produced positive results in 30 patients (36.5%); 16 (53%) and three (5%) cardiac events occurred in positive and negative stress test groups, respectively. At multivariate analysis, only positive DET response (P=0.000002), left ventricular mass index (P=0.028) and a family history of CAD (P=0.037) were independent predictors. The two-year event-free survival rates were 95% and 47% (log-rank 21.093, P=0.00001) for negative and positive stress test results, respectively.
  
  
  CONCLUSIONS
  DET is a useful tool in the prognostic assessment of coronary events in this particular subgroup of patients with hypertension.
authors.affiliation: Istituto di Clinica Medica, Univerità di Siena, Italy. mondillo@unisi.it
authors.forename: S
authors.initials: S
authors.lastname: Mondillo
authors.forename: E
authors.initials: E
authors.lastname: Agricola
authors.forename: T
authors.initials: T
authors.lastname: Ammaturo
authors.forename: F
authors.initials: F
authors.lastname: Guerrini
authors.forename: R
authors.initials: R
authors.lastname: Barbati
authors.forename: M
authors.initials: M
authors.lastname: Focardi
authors.forename: A
authors.initials: A
authors.lastname: Picchi
authors.forename: P
authors.initials: P
authors.lastname: Ballo
authors.forename: R
authors.initials: R
authors.lastname: Nami
mesh_terms: D000368:Aged; D002637:Chest Pain / Q000150:complications*; D003327:Coronary Disease / Q000175:diagnosis* / Q000209:etiology; D004176:Dipyridamole; D004452:Echocardiography / Q000379:methods*; D004562:Electrocardiography; D022062:Electrophysiologic Techniques, Cardiac; D005080:Exercise Test / Q000379:methods; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications*; D017379:Hypertrophy, Left Ventricular / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment
chemical_list: D004176:Dipyridamole